Click Orlando – April 26
For instance, Grossi drives from Orlando to the Moffitt Cancer Center frequently. She has a couple of patients that she’s been driving for several years back and forth, Coover said.
Healio – April 2019
In this installment of In Practice, Frederick L. Locke, MD, Co-Leader of the Immunology Program and Director of the Immune Cell Therapy Program at Moffitt Cancer Center, discusses the side effects and toxicities of CAR T-cell treatments.
WFLA – April 25
Monday marked a major milestone for Jessica. It was her final chemotherapy treatment at Moffitt Cancer Center in in Tampa after fighting a non-stop, grueling battle.
R&D – April 24
Researchers in Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence have discovered a signaling pathway between cytokines and BRAF that promotes tumor growth.
eCancer – April 25
Researchers in Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence have discovered a signalling pathway between cytokines and BRAF that promotes tumour growth.
Tampa Bay Inno – April 24
Co-founder and chief medical officer Dr. Rebecca Sutphen used to manage the genetic programs at both the Moffitt Cancer Center and Johns Hopkins All Children’s Hospital. During that time, Dr. Sutphen noticed a lack of access to genetics experts in local community settings, outside of large academic centers.
The Boca Voice – April 23
A longtime advocate for skin cancer research, particularly for melanoma, Nachlas’ race proceeds last year went to Melanoma Research at the Moffitt Center and the Richard David Kann Melanoma Foundation. Several local nonprofits with screening programs and treatment also received benefits.
OncLive – April 22
Bijal D. Shah, MD, oncologist/hematologist, Moffitt Cancer Center, discusses ongoing trials in the field of mantle cell lymphoma (MCL).
Medical Health News – April 22
CRASH and other oncology assessment tools for seniors can be found at the Moffit Cancer Center website.
OncLive – April 19
Bijal D. Shah, MD, associate member, Department of Malignant Hematology, Moffitt Cancer Center, assistant professor of oncology, University of South Florida, discusses challenges with conducting clinical trials in mantle cell lymphoma (MCL).
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.